![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2020
Silverberg, Jonathan; Pinter, Andreas; Pulka, Grazyna; Poulin, Yves; Bouaziz, Jean-David; Wollenberg, Andreas; Murrell, Dedee F.; Alexis, Andrew; Lindsey, Lisa; Ahmad, Faiz; Piketty, Christophe und Clucas, Alan
(2020):
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus.
In: Journal of Allergy and Clinical Immunology, Bd. 145, Nr. 1: S. 173-182
2018
Kabashima, Kenji; Furue, Masutaka; Hanifin, Jon M.; Pulka, Grazyna; Wollenberg, Andreas; Galus, Ryszard; Etoh, Takafumi; Mihara, Ryosuke; Nakano, Miwa und Ruzicka, Thomas
(2018):
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study.
In: Journal of Allergy and Clinical Immunology, Bd. 142, Nr. 4: S. 1121-1130
2017
Ruzicka, Thomas; Hanifin, Jon M.; Furue, Masutaka; Pulka, Grazyna; Mlynarczyk, Izabela; Wollenberg, Andreas; Galus, Ryszard; Etoh, Takafumi; Mihara, Ryosuke; Yoshida, Hiroki; Stewart, Jonathan und Kabashima, Kenji
(2017):
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
In: New England Journal of Medicine, Bd. 376, Nr. 9: S. 826-835